OPKO Health (OPK)
(Delayed Data from NSDQ)
$1.36 USD
-0.10 (-6.85%)
Updated Oct 31, 2025 04:00 PM ET
After-Market: $1.40 +0.04 (2.94%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
OPK 1.36 -0.10(-6.85%)
Will OPK be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for OPK based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for OPK
OPK Q3 Earnings Beat Estimates, Sales Miss, Gross Margin Expands
Compared to Estimates, OPKO Health (OPK) Q3 Earnings: A Look at Key Metrics
OPK: What are Zacks experts saying now?
Zacks Private Portfolio Services
OPKO Health (OPK) Q3 Earnings Surpass Estimates
Here's Why You Should Add OPKO Health Stock to Your Portfolio
LH Stock Rises on Acquisition of BioReference Health's Select Assets
Other News for OPK
Insider Moves: Crown Castle, Serve Robotics, Las Vegas Sands, Opko Health, and Interactive Brokers Stocks in Focus
Fell Below 50 Day Moving Average appears for OPK after 6.85% move
Starbucks, Opko Health, Roblox, Cloudflare, Apple: Trending by Analysts
Jefferies Downgrades OPK: Price Target Lowered by 20% | OPK Stock News
Opko Health’s CEO Makes Bold Move with Major Stock Purchase